Cargando…
VaxArray potency assay for rapid assessment of “pandemic” influenza vaccines
The VaxArray Influenza Pandemic HA (VXI-pHA) potency assay is a multiplexed sandwich immunoassay that consists of nine broadly reactive yet subtype-specific monoclonal capture antibodies printed in microarray format and a suite of fluor-labeled secondary antibodies that were selected to probe conser...
Autores principales: | Byrne-Nash, Rose T., Miller, David F., Bueter, Katie M., Gillis, Jacob H., Kuck, Laura R., Rowlen, Kathy L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6175820/ https://www.ncbi.nlm.nih.gov/pubmed/30323954 http://dx.doi.org/10.1038/s41541-018-0080-6 |
Ejemplares similares
-
Multiplexed VaxArray immunoassay for rapid antigen quantification in measles and rubella vaccine manufacturing
por: Gillis, Jacob H., et al.
Publicado: (2021) -
A neuraminidase potency assay for quantitative assessment of neuraminidase in influenza vaccines
por: Byrne-Nash, Rose T., et al.
Publicado: (2019) -
VaxArray immunoassay for the multiplexed quantification of poliovirus D-antigen
por: Dawson, Erica D., et al.
Publicado: (2022) -
30-Minute Highly Multiplexed VaxArray Immunoassay for Pneumococcal Vaccine Antigen Characterization
por: Hu, Tianjing, et al.
Publicado: (2022) -
Titer on Chip: New Analytical Tool for Influenza Vaccine Potency Determination
por: Kuck, Laura R., et al.
Publicado: (2014)